Emergent BioSolutions Inc. (EBS) NYSE

9.00

+0.155(+1.75%)

Updated at August 18 02:42PM

Currency In USD

Valuation

Market Cap506.68M
Enterprise Value1.07B
P/E Ratio3.49
PEG Ratio0.02
Price/Sales Ratio0.57
Price/Book Ratio0.91
Enterprise/Revenue1.04
Enterprise/EBITDA2.71

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.16
Operating Margin0.13

Management Effectiveness

Return On Assets0.1
Return On Equity0.27

Income Statement

Revenue1.01B
Revenue/Share15.61
Gross Profit305.2M
EBITDA36.9M
Net Income-190.6M
Diluted EPS-3.6

Balance Sheet

Total Cash267.3M
Total Cash/Share4.93
Total Debt667.8M
Total Debt/Equity1.25
Current Ratio5.66
Book Value Per Share9.89

Price History

52-Week Change-25.66
52-Week High13.28
52-Week Low4.02
Moving Average 50 Days6.95
Moving Average 200 Days7.52

Statistics

Average Volume1.31M
Shares Outstanding53.35M
% Held by Institutions66.53

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A